# Sternal Wound Infection after Cardiac Surgery: Management and Outcome

**Authors:** Marie Dubert, Annabelle Pourbaix, Soleiman Alkhoder, Guillaume Mabileau, François-Xavier Lescure, Walid Ghodhbane, Sabine Belorgey, Christophe Rioux, Laurence Armand-Lefèvre, Michel Wolff, Richard Raffoul, Patrick Nataf, Yazdan Yazdanpanah, Jean-Christophe Lucet

PMC · DOI: 10.1371/journal.pone.0139122 · PLoS ONE · 2015-09-30

## TL;DR

This study examines the management and outcomes of sternal wound infections after cardiac surgery, finding that CDC-defined severe infections have worse outcomes despite similar treatments.

## Contribution

The study provides insights into the management and outcomes of sternal wound infections using a single-center analysis with Redon drains.

## Key findings

- CDC+ SWI patients had a 17% mortality rate compared to 3% in CDC- SWI patients.
- Failure was associated with female gender, higher EuroScore, and ICU stay.
- CDC+ and CDC- SWI had similar rates of superinfection and need for second reoperation.

## Abstract

Sternal Wound Infection (SWI) is a severe complication after cardiac surgery. Debridement associated with primary closure using Redon drains (RD) is an effective treatment, but data on RD management and antibiotic treatment are scarce.

We performed a single-center analysis of consecutive patients who were re-operated for SWI between 01/2009 and 12/2012. All patients underwent a closed drainage with RD (CDRD). Patients with endocarditis or those who died within the first 45 days were excluded from management analysis. RD fluid was cultured twice weekly. Variables recorded were clinical and biological data at SWI diagnosis, severity of SWI based on criteria for mediastinitis as defined by the Centers for Disease Control (CDC), antibiotic therapy, RD management and patient’s outcome.

160 patients developed SWI, 102 (64%) fulfilled CDC criteria (CDC+) and 58 (36%) did not (CDC- SWI). Initial antibiotic treatment and surgical management were similar in CDC+ and CDC- SWI. Patients with CDC+ SWI had a longer duration of antibiotic therapy and a mortality rate of 17% as compared to 3% in patients with CDC- SWI (p = 0.025). Rates of superinfection (10% and 9%) and need for second reoperation (12% and 17%) were similar. Failure (death or need for another reoperation) was associated with female gender, higher EuroScore for prediction of operative mortality, and stay in the ICU.

In patients with SWI, initial one-stage surgical debridement with CDRD is associated with favorable outcomes. CDC+ and CDC- SWI received essentially the same management, but CDC+ SWI has a more severe outcome.

## Linked entities

- **Diseases:** endocarditis (MONDO:0005025)

## Full-text entities

- **Diseases:** Fever (MESH:D005334), inflammatory (MESH:D007249), VAC (MESH:D015812), SWI (MESH:D014946), pericardial effusion (MESH:D010490), osteoarticular infection (MESH:D014394), RD colonization (MESH:D003108), bacteraemia (MESH:C531821), shock (MESH:D012769), Methicillin-resistant staphylococcus aureus (MESH:D013203), CoNS (MESH:D064726), CDRD (MESH:D005596), sternal instability (MESH:C537489), hemorrhage (MESH:D006470), infectious disease (MESH:D003141), purulent (MESH:D003234), Infection (MESH:D007239), Mediastinitis (MESH:D008480), bacteremia (MESH:D016470), superinfection (MESH:D015163), sepsis (MESH:D018805), leaks (MESH:D019559), necrosis (MESH:D009336), involvement (MESH:C564676), chest pain (MESH:D002637), death (MESH:D003643), purulent discharge (MESH:D019522), osteo-articular and hip or knee infected (MESH:D009261), Polymicrobial infection (MESH:D060085), CDC (MESH:D007174), endocarditis (MESH:D004696),  (MESH:D013530)
- **Chemicals:** mupirocin (MESH:D016712), aminoglycoside (MESH:D000617), vancomycin (MESH:D014640), cefamandole (MESH:D002435), RD (-), beta-lactam (MESH:D047090), methicillin (MESH:D008712), gentamicin (MESH:D005839),  (MESH:D000900)
- **Species:** Staphylococcus aureus (species) [taxon 1280], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4589393/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC4589393/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC4589393/full.md

---
Source: https://tomesphere.com/paper/PMC4589393